03Jul
Committed to Clarity: FDA’s Dedication to Transparency with the End of ASR
On June 21, the Food and Drug Administration (FDA) released a report titled “Statement on agency’s efforts to increase transparency in medical device reporting.” This report describes updates to FDA’s Medical Device Reporting (MDR) Program, namely...
By:
Morrison & Foerster LLP
Related
On 5 June 2020, the Treasurer of Australia announced reforms to Australia's foreign investment frame...
Read More >
As data breaches continue to make headlines, one of the largest consumer credit reporting agencies i...
Read More >
The Internal Revenue Service issued a Private Letter Ruling (PLR) stating that certain genetic testi...
Read More >
On July 2, 2019, the U.S. Court of Appeals for the Second Circuit handed a significant victory to Ne...
Read More >
On March 6, 2020, President Trump issued an Executive Order (“EO”) instructing the Chinese company...
Read More >
On February 13, 2020, the California Supreme Court struck a blow to brick and mortar retailers in th...
Read More >